Search

everythinglearnresearchcommunity

for

Search:↓

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Cilostazol may help hair grow and could be a new treatment for hair loss.

The FDA did not approve a testosterone drug because of safety concerns.

Finasteride is stable except in high pH, and lactose and magnesium stearate should be replaced in formulations.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

Terazosin and finasteride together cause no major issues.